Date: Mar 27, 2017

Dr. KyoungJun Yoon, Dr. Byungchul Cho, Dr. Sang Min Yoon
Asan Medical Center, Seoul, South Korea

View Paper

Abstract
Purpose:

To asses the potential dosimetric benefits associated with the CyberKnife (CK) tumor tracking capability, wherein an extra margin for respiratory tumor motion is not required, when compared to respiratory-gated volumetric-modulated arc therapy (VMAT) for hepatocellular carcinoma (HCC).

READ MORE